ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

EPRX Eupraxia Pharmaceuticals Inc

3.68
-0.05 (-1.34%)
30 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Eupraxia Pharmaceuticals Inc EPRX 토론토 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.05 -1.34% 3.68 04:59:59
개장가 저가 고가 종가 전일 종가
3.73 3.68 3.83 3.68 3.73
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
11/04/202420:00PRNUSEupraxia Pharmaceuticals Announces Upcoming Presentations at..
08/04/202420:00PRNUSEupraxia Pharmaceuticals To Present at Bloom Burton & Co...
05/04/202420:00PRNCAEupraxia Pharmaceuticals Begins Trading on Nasdaq Today
04/04/202406:00PRNCAEupraxia Pharmaceuticals to Begin Trading on Nasdaq on April..
02/04/202406:01PRNUSEupraxia Pharmaceuticals Reports Fourth Quarter and 2023..
15/03/202421:26GLOBEEupraxia Pharmaceuticals Announces Closing of Overnight..
12/03/202422:41PRNCAL'Organisme canadien de réglementation des investissements..
12/03/202422:39PRNCACanadian Investment Regulatory Organization Trade Resumption..
12/03/202422:31GLOBEEupraxia Pharmaceuticals Announces Pricing of Overnight..
12/03/202405:08GLOBEEupraxia Pharmaceuticals Announces Overnight Marketed..
12/03/202405:06PRNCASuspension de la négociation par l'Organisme canadien de..
12/03/202405:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
06/02/202407:00PRNCAEupraxia Pharmaceuticals Announces Updated Positive Clinical..
01/02/202421:00PRNCAEupraxia Pharmaceuticals Initiates Phase 3 Development..
30/01/202421:00PRNCAEupraxia Pharmaceuticals Announces Positive Data from MRI..
09/01/202408:44PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
12/12/202321:00PRNCAEupraxia Pharmaceuticals Announces Positive Clinical Data in..
11/12/202321:00PRNCAEupraxia Pharmaceuticals Announces Clinical and Corporate..
15/11/202307:01PRNCAEupraxia Pharmaceuticals Reports Third Quarter 2023..
01/11/202320:00PRNCAEupraxia Pharmaceuticals to Present at the 2023 Annual..
11/10/202320:00PRNCAEupraxia Pharmaceuticals Announces Initiation of Second..
12/09/202304:32PRNCAEupraxia Pharmaceuticals to Present at the H.C. Wainwright..
08/09/202306:00PRNCAEupraxia Pharmaceuticals Announces Change of Auditor
07/09/202306:00PRNCAEupraxia Pharmaceuticals Announces Presentation at PAINWeek..
19/08/202308:20PRNCAEupraxia Pharmaceuticals Announces Closing of Non-Brokered..
12/08/202306:00PRNCAEupraxia Pharmaceuticals Reports Second Quarter 2023..
04/08/202320:00PRNCAEupraxia Pharmaceuticals Announces a Non-Brokered Private..
26/06/202320:00PRNCAEupraxia Pharmaceuticals Reports Positive Topline Data in..
16/06/202307:42PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
14/06/202300:04DJNEupraxia Shares Climb After FDA Fast-Track Designation for..
13/06/202320:43DJNEupraxia Pharmaceuticals Gets FDA Fast-Track Designation for..
13/06/202320:00PRNCAEupraxia Pharmaceuticals Receives U.S. FDA Fast Track..
08/06/202320:00PRNCAEupraxia Pharmaceuticals Doses First Patient in Phase 1b/2a..
25/05/202320:00PRNCAEupraxia Pharmaceuticals Announces Last Patient Last Visit..
18/05/202320:00PRNCAEupraxia Pharmaceuticals Announces Appointment of Dr. Mark..
11/05/202320:00PRNCAEupraxia Pharmaceuticals Reports First Quarter 2023..

최근 히스토리

Delayed Upgrade Clock